CML is a myeloproliferative malignancy caused by the BCR-ABL fusion gene, which is the product of the translocation of the ABL gene located on 9q34 to the BCR gene on 22q11 (Mughal et al., 2007). The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.